Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders

ABSTRACT: Background: Fibromyalgia (FM) is associated with sexual dysfunction, though much less is known about the sexual desire, and especially dyadic and solitary sexual desire, among women with fibromyalgia. Aim: To investigate on the one hand the global sexual desire, the dyadic sexual and soli...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Roel Van Overmeire, PhD, Lara Vesentini, PhD, Stephanie Vanclooster, PhD, Emilie Muysewinkel, MSc, Johan Bilsen, PhD
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	Fibromyalgia Sexual Desire Depression Medicine R Other systems of medicine RZ201-999
Acceso en línea:	https://doaj.org/article/53a41d17a85f4986860ad2ac0e1ccb7b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:53a41d17a85f4986860ad2ac0e1ccb7b
record_format	dspace
spelling	oai:doaj.org-article:53a41d17a85f4986860ad2ac0e1ccb7b2021-11-26T04:27:23ZSexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders2050-116110.1016/j.esxm.2021.100457https://doaj.org/article/53a41d17a85f4986860ad2ac0e1ccb7b2022-02-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2050116121001379https://doaj.org/toc/2050-1161ABSTRACT: Background: Fibromyalgia (FM) is associated with sexual dysfunction, though much less is known about the sexual desire, and especially dyadic and solitary sexual desire, among women with fibromyalgia. Aim: To investigate on the one hand the global sexual desire, the dyadic sexual and solitary sexual desire, and on the other hand the association with depressive symptoms, fibromyalgia symptoms and medication use among women with fibromyalgia in Flanders, Belgium. Methods: An online survey was spread through the Flemish league for Fibromyalgia Patients to be completed by women with fibromyalgia. The sexual desire inventory-2 (SDI-2) was used to measure sexual desire (global, dyadic, solitary), the VASFIQ for fibromyalgia symptoms, and the PHQ-2 for depressive symptoms, while also including questions on demographic factors (time since FM, age) and medication usage (antidepressants, pain medication, sleeping medication). Main Outcome Measure: Global sexual desire, dyadic sexual desire and solitary sexual desire were studied in relation to depressive symptoms, medication use and fibromyalgia symptoms. Results: One hundred and three women with FM answered the survey. Depressive symptoms were significantly associated with a lower global, dyadic and solitary sexual desire, as was the use of antidepressant medication. The association between solitary sexual desire and depressive symptoms disappeared when controlled for antidepressant medication. Age, fibromyalgia symptoms nor time since diagnosis were significantly associated with any form of sexual desire. Conclusion: Depressive symptoms and antidepressant medication, and not fibromyalgia symptoms, were associated with decreased sexual desire of women with FM. As antidepressant medication and depressive symptoms are associated with a decreased sexual desire, more attention should be paid towards the mental health issues associated with fibromyalgia, as well as the prescription of antidepressant medication. This study is the first to investigate sexual desire among women with fibromyalgia in Flanders, and one of the few internationally to have done so. It is limited by its cross-sectional design, and for not providing information on men with FM.Van Overmeire R, Vesentini L, Vanclooster S, et al., Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders. Sex Med 2021;XX:XXXXXX.Roel Van Overmeire, PhDLara Vesentini, PhDStephanie Vanclooster, PhDEmilie Muysewinkel, MScJohan Bilsen, PhDElsevierarticleFibromyalgiaSexual DesireDepressionMedicineROther systems of medicineRZ201-999ENSexual Medicine, Vol 10, Iss 1, Pp 100457- (2022)
institution	DOAJ
collection	DOAJ
language	EN
topic	Fibromyalgia Sexual Desire Depression Medicine R Other systems of medicine RZ201-999
spellingShingle	Fibromyalgia Sexual Desire Depression Medicine R Other systems of medicine RZ201-999 Roel Van Overmeire, PhD Lara Vesentini, PhD Stephanie Vanclooster, PhD Emilie Muysewinkel, MSc Johan Bilsen, PhD Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders
description	ABSTRACT: Background: Fibromyalgia (FM) is associated with sexual dysfunction, though much less is known about the sexual desire, and especially dyadic and solitary sexual desire, among women with fibromyalgia. Aim: To investigate on the one hand the global sexual desire, the dyadic sexual and solitary sexual desire, and on the other hand the association with depressive symptoms, fibromyalgia symptoms and medication use among women with fibromyalgia in Flanders, Belgium. Methods: An online survey was spread through the Flemish league for Fibromyalgia Patients to be completed by women with fibromyalgia. The sexual desire inventory-2 (SDI-2) was used to measure sexual desire (global, dyadic, solitary), the VASFIQ for fibromyalgia symptoms, and the PHQ-2 for depressive symptoms, while also including questions on demographic factors (time since FM, age) and medication usage (antidepressants, pain medication, sleeping medication). Main Outcome Measure: Global sexual desire, dyadic sexual desire and solitary sexual desire were studied in relation to depressive symptoms, medication use and fibromyalgia symptoms. Results: One hundred and three women with FM answered the survey. Depressive symptoms were significantly associated with a lower global, dyadic and solitary sexual desire, as was the use of antidepressant medication. The association between solitary sexual desire and depressive symptoms disappeared when controlled for antidepressant medication. Age, fibromyalgia symptoms nor time since diagnosis were significantly associated with any form of sexual desire. Conclusion: Depressive symptoms and antidepressant medication, and not fibromyalgia symptoms, were associated with decreased sexual desire of women with FM. As antidepressant medication and depressive symptoms are associated with a decreased sexual desire, more attention should be paid towards the mental health issues associated with fibromyalgia, as well as the prescription of antidepressant medication. This study is the first to investigate sexual desire among women with fibromyalgia in Flanders, and one of the few internationally to have done so. It is limited by its cross-sectional design, and for not providing information on men with FM.Van Overmeire R, Vesentini L, Vanclooster S, et al., Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders. Sex Med 2021;XX:XXXXXX.
format	article
author	Roel Van Overmeire, PhD Lara Vesentini, PhD Stephanie Vanclooster, PhD Emilie Muysewinkel, MSc Johan Bilsen, PhD
author_facet	Roel Van Overmeire, PhD Lara Vesentini, PhD Stephanie Vanclooster, PhD Emilie Muysewinkel, MSc Johan Bilsen, PhD
author_sort	Roel Van Overmeire, PhD
title	Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders
title_short	Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders
title_full	Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders
title_fullStr	Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders
title_full_unstemmed	Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders
title_sort	sexual desire, depressive symptoms and medication use among women with fibromyalgia in flanders
publisher	Elsevier
publishDate	2022
url	https://doaj.org/article/53a41d17a85f4986860ad2ac0e1ccb7b
work_keys_str_mv	AT roelvanovermeirephd sexualdesiredepressivesymptomsandmedicationuseamongwomenwithfibromyalgiainflanders AT laravesentiniphd sexualdesiredepressivesymptomsandmedicationuseamongwomenwithfibromyalgiainflanders AT stephanievancloosterphd sexualdesiredepressivesymptomsandmedicationuseamongwomenwithfibromyalgiainflanders AT emiliemuysewinkelmsc sexualdesiredepressivesymptomsandmedicationuseamongwomenwithfibromyalgiainflanders AT johanbilsenphd sexualdesiredepressivesymptomsandmedicationuseamongwomenwithfibromyalgiainflanders
_version_	1718409901273776128

Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders

Ejemplares similares